Post
Regeneron’s bispecific lymphoma antibody odronextamab wins FDA priority review
The US Food and Drug Administration (FDA) has accepted the priority review of the biologics license application (BLA) for Regeneron …
Cambridge biotech Thymmune wins $37m NIH grant for thymic cell therapies
The US Department of Health and Human Services has awarded $37m in funding to Thymmune Therapeutics to accelerate the startup …
Karuna Therapeutics files for FDA approval for schizophrenia treatment
Karuna Therapeutics has announced the submission of a new drug application (NDA) to the US Food and Drug Administration for …
ModeX wins $168m BARDA contract to develop viral antibody therapies
The US Biomedical Advanced Research and Development Authority (BARDA) has awarded a $168m Project NextGen contract to ModeX Therapeutics to …
Can reforms restore faith in India’s pharma industry after cough syrup scandals?
India is known as the 'pharmacy of the world', producing a substantial quantity of generic drugs globally. However, its lax …
Leading providers of washing, disinfection and sterilisation equipment and services
The pharmaceutical industry demands strict adherence to quality and safety standards, making washing, disinfection, and sterilisation equipment crucial components. Choosing the …
AI is a pillar of tomorrow’s healthcare system, but limitations remain
Experts in the biotech and medtech industries descended upon Europe’s geographical centre last week to discuss all things life sciences. …
Amicus receives FDA approval for Pompe disease therapy
Amicus Therapeutics has received approval from the US Food and Drug Administration (FDA) for a two-component therapy, Pombiliti (cipaglucosidase alfa-atga) …
HitGen and SGC enter drug discovery partnership
Chinese company HitGen and the Structural Genomics Consortium (SGC) have entered a research collaboration to discover drugs based on a deoxyribonucleic acid …
Deka Biosciences secures $20m to advance product pipeline
Deka Biosciences has secured funding of $20m in a Series B2 financing round to advance its product pipeline. MPM BioImpact led the funding …
Fabre-Kramer gains FDA approval for major depressive disorder therapy
Fabre-Kramer Pharmaceuticals has obtained approval from the US Food and Drug Administration (FDA) for Exxua (gepirone hydrochloride extended-release tablets) to …
Pfizer gains FDA approval for rare childhood leukaemia drug
The US Food and Drug Administration (FDA) has expanded the label for Pfizer’s cancer drug Bosulif (bosutinib) to include its …
Generative AI-focused biotech startup Evozyne raises $81m
Deep learning biotech Evozyne has closed a Series B investment round worth $81m to advance its generative artificial intelligence (AI)-driven …
Small-cap companies lead the oncology pipeline by programmes in development
It is common for biopharmaceutical companies that start as private entities to become public companies soon after their key pipeline …
Pharmaceutical Technology Excellence Awards 2023: Apprentice.io
Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our …